Linkedin-in

Investor Relations

Lipocine is a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery. 

NASDAQLPCN
YearTrailing 12-MonthsCalendar Year 2026Calendar Year 2025Calendar Year 2024Calendar Year 2023Calendar Year 2022Calendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2017Calendar Year 2016Calendar Year 2015Calendar Year 2014Calendar Year 2013Calendar Year 2012Calendar Year 2011
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Proxy & Information StatementsOther
FormDescriptionDateFormat
SCHEDULE 13GSCHEDULE 13GMay 15, 2026Open SCHEDULE 13G in HTML.Open SCHEDULE 13G in DOC file.Open SCHEDULE 13G in PDF file.Open SCHEDULE 13G in XLS file.
SCHEDULE 13G/ASCHEDULE 13G/AMay 15, 2026Open SCHEDULE 13G/A in HTML.Open SCHEDULE 13G/A in DOC file.Open SCHEDULE 13G/A in PDF file.Open SCHEDULE 13G/A in XLS file.
SCHEDULE 13G/ASCHEDULE 13G/AFeb 17, 2026Open SCHEDULE 13G/A in HTML.Open SCHEDULE 13G/A in DOC file.Open SCHEDULE 13G/A in PDF file.Open SCHEDULE 13G/A in XLS file.
SCHEDULE 13GSCHEDULE 13GDec 23, 2025Open SCHEDULE 13G in HTML.Open SCHEDULE 13G in DOC file.Open SCHEDULE 13G in PDF file.Open SCHEDULE 13G in XLS file.

Innovating beyond boundaries for patients

Krista Fogarty phone: (801) 994-7383 email: kf@lipocine.com